Free Trial

Evolent Health (EVH) Short Interest Ratio & Short Volume

$21.19
-0.34 (-1.58%)
(As of 05/31/2024 ET)

Evolent Health Short Interest Data

Current Short Interest
11,190,000 shares
Previous Short Interest
11,250,000 shares
Change Vs. Previous Month
-0.53%
Dollar Volume Sold Short
$263.52 million
Short Interest Ratio
10.3 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
116,210,000 shares
Percentage of Shares Shorted
9.63%
Today's Trading Volume
1,715,982 shares
Average Trading Volume
1,654,570 shares
Today's Volume Vs. Average
104%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Evolent Health ?

Sign up to receive the latest short interest report for Evolent Health and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EVH Short Interest Over Time

EVH Days to Cover Over Time

EVH Percentage of Float Shorted Over Time

Evolent Health Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/202411,190,000 shares $263.52 million -0.5%N/A10.3 $23.55
4/30/202411,250,000 shares $312.30 million -1.1%N/A12 $27.76
4/15/202411,380,000 shares $344.70 million +7.3%N/A12.2 $30.29
3/31/202410,610,000 shares $347.90 million -1.9%N/A11 $32.79
3/15/202410,810,000 shares $353.16 million -3.8%N/A11 $32.67
2/29/202411,240,000 shares $381.15 million -0.7%N/A8.9 $33.91
2/15/202411,320,000 shares $353.58 million +1.2%N/A8.1 $31.24
1/31/202411,190,000 shares $329.10 million +3.7%N/A8.6 $29.41
1/15/202410,790,000 shares $339.67 million +0.9%N/A7.8 $31.48
12/31/202310,690,000 shares $353.09 million -3.9%N/A7.7 $33.03
12/15/202311,120,000 shares $337.38 million +42.0%N/A8.3 $30.34
11/30/20237,830,000 shares $217.60 million -5.2%N/A6 $27.79
11/15/20238,260,000 shares $245.32 million +0.5%N/A8.5 $29.70
10/31/20238,220,000 shares $200.81 million -1.2%N/A8.4 $24.43
10/15/20238,320,000 shares $232.96 million +0.1%N/A9.5 $28.00
9/30/20238,310,000 shares $226.28 million +9.3%N/A9.2 $27.23
9/15/20237,600,000 shares $199.12 million +5.1%N/A7 $26.20
8/31/20237,230,000 shares $184.37 million -1.4%N/A6.2 $25.50
8/15/20237,330,000 shares $204.87 million -1.5%N/A6 $27.95
7/31/20237,440,000 shares $226.10 million -11.4%N/A6 $30.39
7/15/20238,400,000 shares $254.10 million -1.1%N/A6.6 $30.25
6/30/20238,490,000 shares $257.12 million +36.9%N/A6.8 $30.29
6/15/20236,200,000 shares $185.07 million -1.4%N/A5.4 $29.85
5/31/20236,290,000 shares $183.35 million +8.6%N/A6.8 $29.15
5/15/20235,790,000 shares $201.78 million +9.7%N/A5.9 $34.85
4/30/20235,280,000 shares $192.24 million +3.1%N/A5.7 $36.41
4/15/20235,120,000 shares $168.35 million -4.7%N/A5.9 $32.88
3/31/20235,370,000 shares $174.26 million +3.7%N/A5.7 $32.45
3/15/20235,180,000 shares $156.90 million -9.4%N/A5.3 $30.29
2/28/20235,720,000 shares $200.26 million -2.4%N/A6 $35.01
2/15/20235,860,000 shares $197.01 million -8.7%N/A6.2 $33.62
1/31/20236,420,000 shares $206.85 million -12.9%N/A6 $32.22
1/15/20237,370,000 shares $233.33 million -0.8%N/A6.5 $31.66
12/30/20227,430,000 shares $208.63 million +7.2%N/A6.6 $28.08
12/15/20226,930,000 shares $192.03 million -6.5%N/A6.2 $27.71
11/30/20227,410,000 shares $213.33 million +3.5%N/A6.4 $28.79
11/15/20227,160,000 shares $182.15 million +11.7%N/A5.9 $25.44
10/31/20226,410,000 shares $203.90 million -4.0%N/A5.4 $31.81
10/15/20226,680,000 shares $207.75 million -4.4%N/A5.9 $31.10
9/30/20226,990,000 shares $251.15 million +5.4%N/A6.4 $35.93
Biotech's Best Kept Secret: Potential 46,751% Gain (Ad)

The world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!

Get the name of the stock here >>>
9/15/20226,630,000 shares $258.04 million +3.6%N/A5.8 $38.92
8/31/20226,400,000 shares $235.20 million -24.4%N/A5.8 $36.75
8/15/20228,460,000 shares $288.57 million -1.3%N/A8.3 $34.11
7/31/20228,570,000 shares $291.29 million +1.8%N/A9.5 $33.99
7/15/20228,420,000 shares $270.28 million +3.1%N/A10.2 $32.10
6/30/20228,170,000 shares $250.90 million +0.6%N/A10.2 $30.71
6/15/20228,120,000 shares $223.95 million +0.5%N/A10.8 $27.58
5/31/20228,080,000 shares $227.29 million +8.5%N/A11.3 $28.13
5/15/20227,450,000 shares $208.38 million No ChangeN/A9.9 $27.97
4/30/20227,450,000 shares $205.02 million +1.6%N/A10.4 $27.52
4/15/20227,330,000 shares $222.32 million -0.1%N/A10.8 $30.33
3/31/20227,340,000 shares $237.08 million -3.3%N/A10.5 $32.30
3/15/20227,590,000 shares $219.88 million +5.6%N/A12.3 $28.97
2/28/20227,190,000 shares $191.61 million -1.5%N/A12 $26.65
2/15/20227,300,000 shares $178.56 million +4.7%8.5%12.7 $24.46
1/31/20226,970,000 shares $165.26 million +1.0%8.0%12.6 $23.71
1/15/20226,900,000 shares $174.98 million +1.6%8.0%12.5 $25.36
12/31/20216,790,000 shares $187.88 million -2.2%7.8%11.5 $27.67
12/15/20216,940,000 shares $186.13 million -7.6%8.0%8.3 $26.82
11/30/20217,510,000 shares $195.26 million -8.4%8.7%9 $26.00
11/15/20218,200,000 shares $225.91 million -2.5%9.5%9.7 $27.55
10/29/20218,410,000 shares $246.16 million -1.1%N/A10.2 $29.27
10/15/20218,500,000 shares $254.41 million -6.2%10.0%10.3 $29.93
9/30/20219,060,000 shares $280.86 million -4.0%10.7%12.3 $31.00
9/15/20219,440,000 shares $248.74 million +3.6%11.1%18.8 $26.35
8/31/20219,110,000 shares $223.74 million +4.1%10.7%18.3 $24.56
8/13/20218,750,000 shares $208.60 million +2.5%10.3%17.8 $23.84
7/30/20218,540,000 shares $195.91 million -1.2%10.1%17.1 $22.94
7/15/20218,640,000 shares $192.33 million +3.9%10.2%17.2 $22.26
6/30/20218,320,000 shares $175.72 million -0.5%9.9%16.4 $21.12
6/15/20218,360,000 shares $167.20 million +0.8%9.9%16.9 $20.00
5/28/20218,290,000 shares $161.07 million +0.6%9.8%15.4 $19.43
5/14/20218,240,000 shares $155.65 million -3.9%N/A14 $18.89
4/30/20218,570,000 shares $185.63 million +4.5%N/A15 $21.66
4/15/20218,200,000 shares $164.66 million -3.0%N/A14.1 $20.08
3/31/20218,450,000 shares $169 million +1.4%N/A14.3 $20.00
3/15/20218,330,000 shares $170.43 million -3.6%N/A14.3 $20.46
2/26/20218,640,000 shares $169.60 million +3.4%N/A15.7 $19.63
2/12/20218,360,000 shares $166.87 million -1.4%N/A15.3 $19.96
1/29/20218,480,000 shares $148.06 million -0.7%N/A14.2 $17.46
1/15/20218,540,000 shares $152.10 million -2.8%N/A14 $17.81
12/31/20208,790,000 shares $142.93 million +0.8%N/A14.1 $16.26
12/15/20208,720,000 shares $127.92 million -0.9%N/A11.9 $14.67
11/30/20208,800,000 shares $133.67 million -2.4%N/A10.9 $15.19
11/15/20209,020,000 shares $119.15 million -1.4%N/A10.2 $13.21
10/30/20209,150,000 shares $93.24 million -3.1%N/A8.6 $10.19
10/15/20209,440,000 shares $110.64 million -5.9%N/A7.7 $11.72
9/30/202010,030,000 shares $124.47 million -11.2%N/A7.2 $12.41
9/15/202011,290,000 shares $144.74 million -6.5%N/A7.5 $12.82
8/31/202012,070,000 shares $172.96 million +10.9%N/A7.5 $14.33
Biotech's Best Kept Secret: Potential 46,751% Gain (Ad)

The world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!

Get the name of the stock here >>>
8/14/202010,880,000 shares $137.20 million -4.7%N/A5.6 $12.61
7/31/202011,420,000 shares $133.04 million -14.8%N/A6.3 $11.65
7/15/202013,410,000 shares $109.29 million +7.8%N/A7.6 $8.15
6/30/202012,440,000 shares $85.21 million +14.2%N/A7.7 $6.85
6/15/202010,890,000 shares $64.80 million +8.5%N/A7.1 $5.95
5/29/202010,040,000 shares $89.16 million +0.6%N/A6.5 $8.88
5/15/20209,980,000 shares $75.65 million +1.0%N/A8.2 $7.58
4/30/20209,880,000 shares $71.23 million -3.5%N/A8.4 $7.21
4/15/202010,240,000 shares $59.90 million -1.5%N/A9.4 $5.85
3/31/202010,400,000 shares $70.72 million -19.3%N/A8.7 $6.80
3/13/202012,892,300 shares $80.06 million -2.5%N/A9 $6.21
2/28/202013,220,000 shares $54.33 million -8.6%N/A9.2 $4.11
2/14/202014,470,000 shares $112.29 million -3.0%N/A8.1 $7.76
1/31/202014,910,000 shares $145.37 million -4.3%N/A8.2 $9.75
1/15/202015,580,000 shares $169.04 million -4.5%N/A8.3 $10.85
12/31/201916,320,000 shares $178.54 million -4.7%N/A9.2 $10.94

EVH Short Interest - Frequently Asked Questions

What is Evolent Health's current short interest?

Short interest is the volume of Evolent Health shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 11,190,000 shares of EVH short. Learn More on Evolent Health's current short interest.

What is a good short interest ratio for Evolent Health?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EVH shares currently have a short interest ratio of 10.0. Learn More on Evolent Health's short interest ratio.

Which institutional investors are shorting Evolent Health?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Evolent Health: Walleye Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Evolent Health's short interest increasing or decreasing?

Evolent Health saw a decrease in short interest in May. As of May 15th, there was short interest totaling 11,190,000 shares, a decrease of 0.5% from the previous total of 11,250,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Evolent Health's short interest compare to its competitors?

Here is how the short interest of companies compare to Evolent Health: R1 RCM Inc. (8.22%), Premier, Inc. (5.50%), Franklin Covey Co. (6.62%), Gartner, Inc. (1.61%), Lattice Semiconductor Co. (8.76%), EPAM Systems, Inc. (1.43%), CyberArk Software Ltd. (4.37%), Twilio Inc. (1.55%), F5, Inc. (4.16%), Guidewire Software, Inc. (3.32%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Evolent Health stock?

Short selling EVH is an investing strategy that aims to generate trading profit from Evolent Health as its price is falling. EVH shares are trading down $0.34 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Evolent Health?

A short squeeze for Evolent Health occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EVH, which in turn drives the price of the stock up even further.

How often is Evolent Health's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVH, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NYSE:EVH) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners